Source: The Business Journals: Boston

Orna: Months after acquisition, Watertown RNA biotech lays off workers

Months after acquiring Cambridge-based ReNAgade Therapeutics, Watertown's Orna Therapeutics has made layoffs as it focuses its pipeline.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Joseph Bolen's photo - CEO of Orna

CEO

Joseph Bolen

CEO Approval Rating

82/100

Read more